MedTrace Logo

Challenge Test for Acetylsalicylic Acid Hypersensitivity

NCT01681615 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-09-13

No results posted yet for this study

Summary

The investigators want to find new challenge test for Acetylsalicylic hypersensitivity / Aspirin hypersensitivity. The investigators suggest that this new test will be as efficient as the already established protocols in terms of sensitivity and specificity.

Conditions

  • Asthma Aspirin-sensitive
  • ASA Intolerant Asthma
  • Asthma, Aspirin-Induced
  • Asthma, Nasal Polyps, and Aspirin Intolerance

Interventions

DRUG

Acetylsalicylate

1-2 drops

DRUG

Isotonic NaCl

1 drop

Sponsors & Collaborators

  • University Hospital, Akershus

    collaborator OTHER

  • Helse Stavanger HF

    lead OTHER_GOV

Principal Investigators

  • Gregor Bachmann-Harildstad, MD, PhD · University in Oslo

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-03-31
Completion
2013-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01681615 on ClinicalTrials.gov